Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorPindiprolu, Sai Kiran S. S.-
Autor(es): dc.creatorPindiprolu, Sai Harshini-
Data de aceite: dc.date.accessioned2026-02-09T11:38:16Z-
Data de disponibilização: dc.date.available2026-02-09T11:38:16Z-
Data de envio: dc.date.issued2020-05-26-
Data de envio: dc.date.issued2020-05-26-
Data de envio: dc.date.issued2020-07-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/41236-
Fonte completa do material: dc.identifierhttp://www.sciencedirect.com/science/article/pii/S0306987720305892-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1144073-
Descrição: dc.descriptionCorona virus disease 2019 (COVID-19) pandemic caused 18 440 deaths world wide as of 25 March 2020 and posing a serious threat to public health. There is a need, therefore, for effective therapeutic strategies to cure this disease. However, high attrition rates, substantial costs and slow pace are the major limitations of novel drug discovery. Drug repurposing, by employing ‘old’ drugs to treat ‘new’ diseases is an attractive approach in drug discovery. Niclosamide (NIC) is an approved anti-helminthic drug with diverse antiviral mechanisms. In this work we hypothesize, the potential antiviral mechanisms of NIC against COVID-19.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceMedical Hypotheses-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
Palavras-chave: dc.subjectDrug discovery-
Palavras-chave: dc.subjectRepurposing-
Palavras-chave: dc.subjectNiclosamide-
Título: dc.titlePlausible mechanisms of Niclosamide as an antiviral agent against COVID-19-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.